Mangompit, Bernie E.

HRN: 21-45-68  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2023
CEFUROXIME 750MG (VIAL)
10/10/2023
10/17/2023
IV
750mg
Every 8 Hours
Infected Skin And Muscle Secondary To Lacerated Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: